NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
08/08/2024
Back to search
Official data from USPTO
REATA PHARMACEUTICALS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
REATA PHARMACEUTICALS
ST13
US500000086778679Class
5
Filing
86778679
Registration
5387141
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
40
Latest update
08/08/2024
Trademark type
Word
Nice classes
5
Filing date
10/05/2015
Registration date
01/23/2018
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/08/2024
Last transaction
08/08/2024
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
2012-04-00
First use in commerce
2012-04-00
Drawing code
4
Owner type
03
Owner location
Plano, TX
Examiner
LAPTER, ALAIN
Current location
Historical data usage
Holders and representatives
Holders
Reata Pharmaceuticals, Inc.
Reata Pharmaceuticals, Inc.
Representatives
Andrea Shannon NORTON ROSE FULBRIGHT US LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for the prevention and treatment of disorders of the nervous systemthe cardio-vascular systemthe metabolic systemthe respiratory systemthe musculo-skeletal systemfor use in oncologyophthalmologythe prevention and treatment of gastrointestinal diseasesdiseases and disorders of the immune system including autoimmune diseasesskin diseases
Publications
History of USPTO decisions and trademark events.
40 publications found
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
08/08/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
08/08/2024
E815
TEAS SECTION 8 & 15 RECEIVED
01/23/2024
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
05/24/2023
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
01/23/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
10/12/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
10/12/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
10/12/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
10/12/2020
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
10/12/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
01/23/2018
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
12/21/2017
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
12/20/2017
SUPC
STATEMENT OF USE PROCESSING COMPLETE
12/12/2017
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
12/12/2017
IUAF
USE AMENDMENT FILED
11/29/2017
EISU
TEAS STATEMENT OF USE RECEIVED
11/29/2017
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
06/02/2017
EX2G
SOU EXTENSION 2 GRANTED
05/31/2017
EXT2
SOU EXTENSION 2 FILED
05/31/2017
EEXT
SOU TEAS EXTENSION RECEIVED
05/31/2017
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
12/02/2016
EX1G
SOU EXTENSION 1 GRANTED
11/30/2016
EXT1
SOU EXTENSION 1 FILED
11/30/2016
EEXT
SOU TEAS EXTENSION RECEIVED
11/30/2016
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
05/31/2016
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/05/2016
PUBO
PUBLISHED FOR OPPOSITION
04/05/2016
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/16/2016
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
03/02/2016
ALIE
ASSIGNED TO LIE
03/02/2016
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/28/2016
XAEC
EXAMINER'S AMENDMENT ENTERED
01/28/2016
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
01/28/2016
GNEA
EXAMINERS AMENDMENT E-MAILED
01/28/2016
CNEA
EXAMINERS AMENDMENT -WRITTEN
01/28/2016
DOCK
ASSIGNED TO EXAMINER
01/25/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/08/2015
NWAP
NEW APPLICATION ENTERED
10/08/2015
Continuous trademark protection
Get notified about every new filing that threatens REATA PHARMACEUTICALS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.